PT Kalbe Farma Tbk's book value per share for the quarter that ended in Mar. 2024 was $6.28.
During the past 12 months, PT Kalbe Farma Tbk's average Book Value Per Share Growth Rate was 5.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 7.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 8.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 10.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of PT Kalbe Farma Tbk was 20.60% per year. The lowest was 7.60% per year. And the median was 13.95% per year.
PT Kalbe Farma Tbk's current price is $17.03. Its book value per share for the quarter that ended in Mar. 2024 was $6.28. Hence, today's PB Ratio of PT Kalbe Farma Tbk is 2.71.
During the past 13 years, the highest P/B Ratio of PT Kalbe Farma Tbk was 9.79. The lowest was 2.89. And the median was 4.97.
PT Kalbe Farma Tbk Book Value per Share Historical Data
The historical data trend for PT Kalbe Farma Tbk's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PT Kalbe Farma Tbk's Book Value per Share
For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Kalbe Farma Tbk's PB Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's PB Ratio distribution charts can be found below:
* The bar in red indicates where PT Kalbe Farma Tbk's PB Ratio falls into.
PT Kalbe Farma Tbk Book Value per Share Calculation
PT Kalbe Farma Tbk's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
PT Kalbe Farma Tbk (OTCPK:PTKFY) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
PT Kalbe Farma Tbk Book Value per Share Related Terms
Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Business Description
Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PTKFY has been successfully added to your 